Which carcinoplacental alkaline phosphatase isoenzyme is inhibited by phenylalanine?

Prepare for the Clinical Chemistry Numericals Test. Study with comprehensive questions, each with detailed explanations. Boost your confidence and excel on your exam!

Multiple Choice

Which carcinoplacental alkaline phosphatase isoenzyme is inhibited by phenylalanine?

Explanation:
Phenylalanine sensitivity is a diagnostic clue for identifying placental-type alkaline phosphatase isoenzymes. The Regan isoenzyme, a placental-type ALP associated with certain carcinomas, is inhibited by L-phenylalanine, so introducing phenylalanine reduces its activity. This specific inhibition profile helps distinguish Regan from other placental-like isoenzymes such as Nagao and Kasahara, which do not respond to phenylalanine in the same way. Therefore, observing a drop in ALP activity when phenylalanine is added points to the Regan isoenzyme being present, making it the best answer.

Phenylalanine sensitivity is a diagnostic clue for identifying placental-type alkaline phosphatase isoenzymes. The Regan isoenzyme, a placental-type ALP associated with certain carcinomas, is inhibited by L-phenylalanine, so introducing phenylalanine reduces its activity. This specific inhibition profile helps distinguish Regan from other placental-like isoenzymes such as Nagao and Kasahara, which do not respond to phenylalanine in the same way. Therefore, observing a drop in ALP activity when phenylalanine is added points to the Regan isoenzyme being present, making it the best answer.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy